Dr. Dionysis Papadatos-Pastos

About Dr. Dionysis Papadatos-Pastos

Dr. Dionysis Papadatos-Pastos is an experienced Medical Oncologist specialising in lung cancer, mesothelioma, and thymic tumours.
His sub-specialist interests include immunotherapy and targeted therapies for non-small cell lung cancer, small cell lung cancer, and mesothelioma.
He provides treatments including immunotherapy, targeted therapy, chemotherapy, and participation in early-phase clinical trials.
He completed his Medical degree from the University of Athens with distinction, a PhD in Medical Oncology (focusing on biomarkers) in 2012, and holds a Diploma in Medical Oncology from the Institute of Cancer Research, University of London.
He is a Consultant Medical Oncologist at University College London Hospitals (UCLH) and The Princess Alexandra Hospital NHS Trust since 2016.
Dr. Papadatos-Pastos leads the lung cancer program at the CRUK UCL Clinical Trials Centre and co-chairs the London Clinic Lung Cancer Multidisciplinary Team (MDT).
He is a Member of the Royal College of Physicians (RCP), American Society of Clinical Oncology (ASCO), and British Medical Association (BMA).
Dr. Dionysis Papadatos-Pastos is Chief Investigator in multiple academic and commercial clinical trials focusing on novel targeted therapies and combinations of immunotherapy agents.
He has authored multiple peer-reviewed publications and is actively involved in clinical education and research presentations at national and international oncology conferences.

Conditions treated by Dr. Dionysis Papadatos-Pastos

Non-small cell lung cancer
Small-cell lung cancer
Mesothelioma
Thymoma
Thymic cancer

Area of Interest

Medical oncology

Qualification

MRCP(UK)
MD: Graduated from the University of Athens with distinction.
Diploma in Medical Oncology: Institute of Cancer Research, University of London.
PhD in Medical Oncology: Awarded in 2012 with First Class honours.

Work Experiences

Global Team of Board Certified Surgeons and Medical Specialists
Written Second Opinion report delivered within 5 days
Option to avail the Video Consultation with the Lead Doctor of the board

Access Our most trusted Medical Second Opinion

Telemedicine Doctors

Do you know?

You can book a video consultation with Dr. Dionysis Papadatos-Pastos on our platform

Consult Online

CERTIFICATIONS (1)

MEMBERSHIPS (4)

Royal College of Physicians (RCP): Member
British Medical Association (BMA): Member
American Society of Clinical Oncology (ASCO): Member
Medical Defence Union (MDU): Member

RESEARCH PAPERS AND PUBLICATIONS (3)

Au L, Hatipoglu E, de Massy MR, Litchfield K, Beattie G, Rowan A, Schnidrig D, Thompson R, Byrne F, Horswell S, Fotiadis N. Determinants of anti-PD-1 response and resistance in clear cell renal cell carcinoma. Cancer cell. 2021 Nov 8;39(11):1497-518.
Litchfield K, Stanislaw S, Spain L, Gallegos LL, Rowan A, Schnidrig D, Rosenbaum H, Harle A, Au L, Hill SM, Tippu Z. Representative sequencing: unbiased sampling of solid tumor tissue. Cell reports. 2020 May 5;31(5).
McLeod R, Kumar R, Papadatos-Pastos D, Mateo J, Brown JS, Garces AH, Ruddle R, Decordova S, Jueliger S, Ferraldeschi R, Maiques O. First-in-human study of AT13148, a dual ROCK-AKT inhibitor in patients with solid tumors. Clinical Cancer Research. 2020 Sep 15;26(18):4777-84.

Share Your Experience about Dr. Dionysis Papadatos-Pastos

Write Your Review

PROCEDURES

Chemotherapy
Immunotherapy
Lung Cancer Treatment

FREQUENTLY ASKED QUESTIONS

Is Dr Dionysis Papadatos-Pastos doing teleconsultation on the MediGence platform?

Dr Dionysis Papadatos-Pastos is available to teleconsult on the MediGence platform.

How long is the consultation?

The consultation typically lasts between 15 and 30 minutes. It may exceed the estimated time, depending on the patient’s queries and the doctor's medical suggestions.

How soon can the consultation be organised?

We have Medical specialists and board-certified doctors on our panel of doctors. The consultation will be organised within 24 to 48 hours or based on the availability of the doctor and the patient.

Is a follow-up consultation included in the consultation price?

No, the follow-up consultation fee is not included in the consultation price. The patient will be required to re-book the consultation.

How do I share my medical record with the doctor for review?

The option to share your medical records is available between the steps of the form provided to you on the website.

Can I book my procedure with the doctor after the consultation?

Yes. If you are satisfied with the consultation, you can proceed with treatment packages tailored to your diagnosis, assisted by our case managers.

Can you get an estimate for the procedure?

Yes. The cost estimate will be provided to you by our case manager, including the doctor’s opinion, the cost estimate, and crucial information about travelling to your medical destination.

FAQ's Related to Medical Oncologist

What types of cancer does Dr Dionysis Papadatos-Pastos treat?

Dr Papadatos-Pastos specialises in treating lung cancer (both non-small cell and small cell), mesothelioma, and thymic tumours.

When should I consult a medical oncologist, such as Dr Papadatos-Pastos?

You should see a Medical Oncologist if you have been diagnosed with cancer or if your doctor suspects cancer and you need expert advice on systemic treatments such as chemotherapy, targeted therapy, or immunotherapy.

What treatments does Dr Dionysis Papadatos-Pastos offer?

Dr Papadatos-Pastos provides personalised treatment plans involving immunotherapy, targeted therapy, chemotherapy, and access to early-phase clinical trials.

What is immunotherapy, and how does Dr Papadatos-Pastos use it in treatment?

Immunotherapy uses the body’s immune system to fight cancer. Dr Papadatos-Pastos focuses on combining immunotherapy with targeted treatments to improve outcomes in lung cancer and mesothelioma patients.

Can Dr Dionysis Papadatos-Pastos help me participate in clinical trials?

Yes, Dr Papadatos-Pastos leads and participates in national and international clinical trials, offering patients access to the latest experimental treatments.

Does Dr Papadatos-Pastos specialise in advanced or rare cancers?

Yes, in addition to common lung cancers, he specialises in treating rarer tumours such as mesothelioma and thymic tumours, offering expertise in complex cases where specialised knowledge is essential.

Welcome To MediGence

Your Notifications